跳至主要内容
临床试验/IRCT20141209020250N6
IRCT20141209020250N6已完成3 期

Evaluation of the efficacy and side effects of intralesional methotrexate injection in comparison with intralesional triamcinolone acetonide in patients with alopecia areata in patients referred to Razi Hospital in 2021-2022

Vice chancellor of Research and Technology,Tehran University of Medical Sciences and Health Services0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 60 years(—)
性别
All

入选标准

  • Adult patients (aged 16-60 years)
  • Patients with alopecia areata who have less than 20% involvement of the scalp
  • have not received any treatment for AA in the past 1 month.

排除标准

  • Children and patients under 16 years, pregnant and lactating women, chronic patients including patients with liver or blood disorders, patients with immunodeficiency, infectious disease
  • patients with diffuse types (alopecia totalis, alopecia universalis and more than 20%) and positive pull tests that are candidates for systemic treatment
  • patients who were treated for alopecia areata during the previous month

研究者

发起方
Vice chancellor of Research and Technology,Tehran University of Medical Sciences and Health Services

相似试验